Last reviewed · How we verify

Candida Skin Test Antigen — Competitive Intelligence Brief

Candida Skin Test Antigen (Candida Skin Test Antigen) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Diagnostic antigen / Immunological test. Area: Immunology / Diagnostics.

marketed Diagnostic antigen / Immunological test Immunology / Diagnostics Biologic Live · refreshed every 30 min

Target snapshot

Candida Skin Test Antigen (Candida Skin Test Antigen) — Aeras. Candida skin test antigen is an intradermal diagnostic agent that elicits a delayed-type hypersensitivity reaction to assess cell-mediated immune function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Candida Skin Test Antigen TARGET Candida Skin Test Antigen Aeras marketed Diagnostic antigen / Immunological test
Candida Antigen Candida Antigen University of Arkansas marketed Diagnostic antigen / Immunological test

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Diagnostic antigen / Immunological test class)

  1. Aeras · 1 drug in this class
  2. University of Arkansas · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Candida Skin Test Antigen — Competitive Intelligence Brief. https://druglandscape.com/ci/candida-skin-test-antigen. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: